These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 27018260)
41. Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease. Cras P; Kawai M; Siedlak S; Mulvihill P; Gambetti P; Lowery D; Gonzalez-DeWhitt P; Greenberg B; Perry G Am J Pathol; 1990 Aug; 137(2):241-6. PubMed ID: 2117395 [TBL] [Abstract][Full Text] [Related]
42. Scrapie and Alzheimer's disease. Bruce ME Psychol Med; 1984 Aug; 14(3):497-500. PubMed ID: 6494362 [No Abstract] [Full Text] [Related]
43. Glial levels determine severity of white matter disease in Alzheimer's disease: a neuropathological study of glial changes. Sjöbeck M; Englund E Neuropathol Appl Neurobiol; 2003 Apr; 29(2):159-69. PubMed ID: 12662323 [TBL] [Abstract][Full Text] [Related]
44. Are paradoxical cell cycle activities in neurons and glia related to the metabolic theory of Alzheimer's disease? Erol A J Alzheimers Dis; 2010; 19(1):129-35. PubMed ID: 20061632 [TBL] [Abstract][Full Text] [Related]
48. Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease? Hashimoto M; Kazui H; Matsumoto K; Nakano Y; Yasuda M; Mori E Am J Psychiatry; 2005 Apr; 162(4):676-82. PubMed ID: 15800138 [TBL] [Abstract][Full Text] [Related]
49. A proposed new strategy of immunotherapy for Alzheimer's disease. Gasiorowski K; Leszek J Med Hypotheses; 1997 Oct; 49(4):319-26. PubMed ID: 9352502 [TBL] [Abstract][Full Text] [Related]
50. Towards prevention and therapy of Alzheimer's disease. Pasinetti GM Mol Aspects Med; 2015; 43-44():1-2. PubMed ID: 26449935 [No Abstract] [Full Text] [Related]
51. The "glymphatic" mechanism for solute clearance in Alzheimer's disease: game changer or unproven speculation? Smith AJ; Verkman AS FASEB J; 2018 Feb; 32(2):543-551. PubMed ID: 29101220 [TBL] [Abstract][Full Text] [Related]
54. Brain local and regional neuroglial alterations in Alzheimer's Disease: cell types, responses and implications. Toledano A; Álvarez MI; Toledano-Díaz A; Merino JJ; Rodríguez JJ Curr Alzheimer Res; 2016; 13(4):321-42. PubMed ID: 26567738 [TBL] [Abstract][Full Text] [Related]
55. The Special Topics Section of Alzheimer's & Dementia. Khachaturian ZS; Mesulam MM; Khachaturian AS; Mohs RC Alzheimers Dement; 2015 Nov; 11(11):1261-4. PubMed ID: 26589667 [No Abstract] [Full Text] [Related]
56. Aggregated Aβ1-42 Is Selectively Toxic for Neurons, Whereas Glial Cells Produce Mature Fibrils with Low Toxicity in Drosophila. Jonson M; Nyström S; Sandberg A; Carlback M; Michno W; Hanrieder J; Starkenberg A; Nilsson KPR; Thor S; Hammarström P Cell Chem Biol; 2018 May; 25(5):595-610.e5. PubMed ID: 29657084 [TBL] [Abstract][Full Text] [Related]
57. Glial Cells - The Key Elements of Alzheimer´s Disease. Dzamba D; Harantova L; Butenko O; Anderova M Curr Alzheimer Res; 2016; 13(8):894-911. PubMed ID: 26825092 [TBL] [Abstract][Full Text] [Related]
58. Advances in imaging-genetic relationships for Alzheimer's disease: clinical implications. Bagnoli S; Piaceri I; Sorbi S; Nacmias B Neurodegener Dis Manag; 2014; 4(1):73-81. PubMed ID: 24640981 [TBL] [Abstract][Full Text] [Related]
59. National Institute on Aging - Alzheimer's Association Research Framework lays the groundwork for deeper understanding of Alzheimer's disease. Knopman DS; Siemers ER; Bain LJ; Hendrix JA; Carrillo MC Alzheimers Dement; 2018 Feb; 14(2):261-262. PubMed ID: 29413643 [No Abstract] [Full Text] [Related]
60. Retina: source of the earliest biomarkers for Alzheimer's disease? Krantic S; Torriglia A J Alzheimers Dis; 2014; 40(2):237-43. PubMed ID: 24413614 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]